MTA3
Metastasis-associated protein MTA3
Also known as: KIAA1266, MTA3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BTC8
- Gene
- MTA3
- Ensembl
- ENSG00000057935
- Chromosome
- 2
- Canonical length
- 594 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Vesicles
OverviewNCBI Gene
Predicted to enable histone deacetylase binding activity; transcription coactivator activity; and transcription corepressor activity. Involved in chromatin remodeling and negative regulation of DNA-templated transcription. Located in nucleoplasm. Part of NuRD complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
594 residues, UniProt reviewed canonical sequence.
>Q9BTC8|MTA3
1 MAANMYRVGD YVYFENSSSN PYLIRRIEEL NKTASGNVEA KVVCFYRRRD ISNTLIMLAD
61 KHAKEIEEES ETTVEADLTD KQKHQLKHRE LFLSRQYESL PATHIRGKCS VALLNETESV
121 LSYLDKEDTF FYSLVYDPSL KTLLADKGEI RVGPRYQADI PEMLLEGESD EREQSKLEVK
181 VWDPNSPLTD RQIDQFLVVA RAVGTFARAL DCSSSVRQPS LHMSAAAASR DITLFHAMDT
241 LYRHSYDLSS AISVLVPLGG PVLCRDEMEE WSASEASLFE EALEKYGKDF NDIRQDFLPW
301 KSLTSIIEYY YMWKTTDRYV QQKRLKAAEA ESKLKQVYIP TYSKPNPNQI STSNGKPGAV
361 NGAVGTTFQP QNPLLGRACE SCYATQSHQW YSWGPPNMQC RLCAICWLYW KKYGGLKMPT
421 QSEEEKLSPS PTTEDPRVRS HVSRQAMQGM PVRNTGSPKS AVKTRQAFFL HTTYFTKFAR
481 QVCKNTLRLR QAARRPFVAI NYAAIRAEYA DRHAELSGSP LKSKSTRKPL ACIIGYLEIH
541 PAKKPNVIRS TPSLQTPTTK RMLTTPNHTS LSILGKRNYS HHNGLDELTC CVSDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MTA3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 66 nTPM
Expression across tissuesHPA
Tissue
- thymus: 66 nTPM
- adrenal gland: 33 nTPM
- ovary: 30 nTPM
- epididymis: 26 nTPM
- cerebral cortex: 24 nTPM
- amygdala: 21 nTPM
Single-cell type
- adrenal cortex cells: 346 nCPM
- thyrotrophs: 217 nCPM
- tuft cells: 208 nCPM
- leydig cells: 174 nCPM
- corticotrophs: 165 nCPM
- lactotrophs: 162 nCPM
Immune cell
- naive CD4 T-cell: 4.4 nTPM
- naive CD8 T-cell: 3 nTPM
- memory CD8 T-cell: 2.9 nTPM
- MAIT T-cell: 2.6 nTPM
- basophil: 2.5 nTPM
- memory CD4 T-cell: 2 nTPM
Brain region
- hippocampal formation: 45 nTPM
- cerebral cortex: 41 nTPM
- pons: 40 nTPM
- basal ganglia: 38 nTPM
- amygdala: 34 nTPM
- hypothalamus: 33 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MTA3.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 73 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.52
- gnomAD pLI
- 0.03
- gnomAD missense Z
- 0.66
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chromatin remodeling
- G2/M transition of mitotic cell cycle
- negative regulation of DNA-templated transcription
- negative regulation of transcription by RNA polymerase II
- positive regulation of DNA-templated transcription
- positive regulation of G2/M transition of mitotic cell cycle
- regulation of cell fate specification
- regulation of stem cell differentiation
- granulosa cell proliferation
- positive regulation of granulosa cell proliferation
Molecular functions
- chromatin binding
- histone deacetylase binding
- protein-containing complex binding
- sequence-specific DNA binding
- transcription coactivator activity
- transcription corepressor activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Zinc finger, GATA-type
- ELM2 domain
- SANT/Myb domain
- Bromo adjacent homology (BAH) domain
- Homedomain-like superfamily
- SANT domain
- Metastasis-associated protein MTA1, R1 domain
- Mesoderm induction early response protein/metastasis-associated protein
- Bromo adjacent homology (BAH) domain superfamily
- Myb-like DNA-binding domain
- GATA zinc finger
- BAH domain
- ELM2 domain
- MTA R1 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MTA3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MTA3 as an antibody target. Whether an autoantibody or antibody against MTA3 could matter depends on whether native MTA3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MTA3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MTA3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...